New York University - College of Dentistry
Home The College Research Academic Programs Library/Resources Continuing Education Community Outreach International Programs
Click to View Virtual Tour
Faculty Information

Daniel Malamud, Ph.D.
Professor
Basic Science and Craniofacial Biology
906 Schwartz, 345 East 24 Street
Phone: 212-998-9331
E-mail:

 

Education:

1961 B.S., University of Michigan, Ann Arbor
1962 M.A., Western Michigan University, Kalamazoo
1965 Ph.D., University of Cincinnati

 

Research Interests / Professional Overview:

Dr. Malamud specializes in the development of anti-HIV agents and oral-based diagnostics. The area of oral-based diagnostics is a rapidly evolving field that has developed from the realization that most molecules present in blood can also be detected within the oral cavity, thus providing a relatively non-invasive diagnostic method. Current studies focus on a point-of-care microfluidic cassette that can detect multiple analytes present in bacterial and viral pathogens. A second project deals with alterations in the gastrointestinal track following administration of antiviral therapy to HIV+ individuals. In this study research teams are monitoring proteomics, microbiomics and alterations in the innate immune system. Dr. Malamud's research, which has been continuously funded by the NIH for over 30 years, deals with HIV pathogenesis, the design of anti-HIV drugs, and novel diagnostics using oral samples. His investigations in these areas have involved human salivary proteins that inhibit HIV infectivity and the discovery and development of anti-HIV compounds that can be used to prevent HIV infection.

 

Current Funding:

Anti-HIV activity of lung SRCR (gp340) in saliva - NIDCR

Point detection of pathogens in oral samples via Up-converting phosphor transfer - NIDCR

Crosstalk among oral & gastrointestinal innate factors, HIV & microbes- NIDCR

Role of gp-340 in HIV infection and transmission - NIAID

 

Pub Med Articles:

Malamud D

 

Representative Publications:

Cannon, G, Yi, Y, Stoddard, E, Scales, DA, Van Ryk, DI, Chaiken, I, Malamud, D, Weissman, D. HIV envelope binding by macrophage-expressed gp340 promotes HIV-1 infection. J Immunol 2008 Aug; 181:2065-2070.

Stoddard, E, Cannon, G, Ni, H, Kariko, K, Capodici, J, Malamud, D, Weissman, D. gp340 expressed on human genital epithelia binds HIV-1 envelope protein and facilitates viral transmission. J Immunol 2007 Sept; 179:3126-3132.

Chen, Z, Mauk, MG, Wang, J, Abrams, WR, Corstjens, PL, Niedbala, RS, Malamud, D, Bau, HH. A microfluidic system for saliva-based detection of infectious diseases. Ann NY Acad Sci 2007 March 1098:429-436.

Malamud, D, Abrams, WR, Bau HH, Wang, J, Chen, Z, Corstjens, P, Niedbala, RS. Oral-based techniques for the diagnosis of infectious diseases. J Calif Dent Assoc 2006 Apr 34(4):297-301.

Malamud, D, Bau H, Niedbala S, Corstjens P. Point detection of pathogens in oral samples. Adv Dent Res. 2005 Jun; 18(1): 12-6.

Slaughter YA, Malamud D. Oral diagnostics for the geriatric populations: current status and future prospects. Dent Clin North Am. 2005 Apr;49(2):445-61.

Barnhart KT, Pretorius ES, Timbers K, Shera D, Shabbout M, Malamud D. In vivo distribution of a vaginal gel: MRI evaluation of the effects of gel volume, time and simulated intercouse. Contraception. 2004 Dec;70(6):498-505.

Holm-Hansen C, Tong G, Davis C, Abrams WR, Malamud D. Comparison of oral fluid collectors for use in a rapid point-of-care diagnostic device. Clin Diagn Lab Immunol. 2004 Sep;11(5):909-12.

Wu Z, Golub E, Abrams WR, Malamud D. gp340 (SAG) binds to the V3 sequence of gp120 important for chemokine receptor interaction. AIDS Res Hum Retroviruses. 2004 Jun;20(6):600-7.

Wu Z, Van Ryk D, Davis C, Abrams WR, Chaiken I, Magnani J, Malamud D. Salivary agglutinin inhibits HIV type 1 infectivity through interaction with viral glycoprotein 120. AIDS Res Hum Retroviruses. 2003 Mar;19(3):201-9.

Pretorius ES, Timbers K, Malamud D, Barnhart K. Magnetic resonance imaging to determine the distribution of a vaginal gel: before, during, and after both simulated and real intercourse. Contraception. 2002 Dec;66(6):443-51.

Shugars DC, Sweet SP, Malamud D, Kazmi SH, Page-Shafer K, Challacombe SJ. Saliva and inhibition of HIV-1 infection: molecular mechanisms. Oral Dis. 2002;8 Suppl 2:169-75. Review.

Malamud, D. (1992) Saliva as a Diagnostic Fluid. British Medical Journal. 305:207 8.

Malamud, D., and Freidman, H.M. (1993) HIV in the oral cavity: Virus, viral inhibitory activity and anti viral antibodies: A review. Crit. Rev. Oral Biol. Med. 4:461 466.

Malamud, D., Davis, C., Berthold, P., Roth, E., and Freidman, H.A. (1993) Human Submandibular Saliva Aggregates HIV. AIDS Research Human Retro. 9:633 637.

Malamud, D. and Tabak, L., (1993) Saliva as a diagnostic fluid. Annals NY Academy of Sciences Volume 694.

Pearce Pratt, R, Malamud, D. and Phillips, D.M. (1994) Role of the Cytoskeleton in Cell to Cell Transmission of Human Immunodeficiency Virus. J. Virology 68:2898 2905.

Malamud, D., Nagashunmugam, T., Davis, C., Kennedy, S., Abrams, W.R,, Kream, R And Friedman, H.M. (1997) Inhibition of HIV infectivity by human saliva. Oral Diseases 3:Suppl 1, S58 S63.

Malamud, D. (1997) Oral diagnostic testing Human Immunodeficiency Virus l antibodies: A technology whose time has come. American Journal of Medicine. 102 (Suppl. 4A):9 14.

Nagashunmugam, T., Friedman, H., Davis, C., Kennedy, S., Goldstein, L.T., and Malamud, D. (1997) Human submandibular saliva specifically inhibits HIV l. AIDS Research and Human Retroviruses. 13:371 376.

Hodinka, R.L., Nagashunmugam, T. and Malamud, D. (1998) Detection of human immunodeficiency virus antibodies in oral fluids: A review. Clin. Diag. Lab. Immunol. 5:419-426.

Taichman, N.S., Cruchley, A.T., Fletcher, L.M., Hagi-Pavli, E.P., Paleolog, E.M., Abrams, W.R., Booth, V., Edwards, R.M., and Malamud, D. (1998) Vascular endothelial growth factor in normal human salivary glands and saliva: A possible role in the maintenance of mucosal homeostasis. Lab Invest 78:869-875.